Aclaris Therapeutics ACRS Increase Decrease In Accounts Receivable Prepaid Expense And Other Assets
Increase Decrease In Accounts Receivable Prepaid Expense And Other Assets at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept acrs:IncreaseDecreaseInAccountsReceivablePrepaidExpenseAndOtherAssets.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's increase decrease in accounts receivable prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's increase decrease in accounts receivable prepaid expense and other assets?
- Aclaris Therapeutics (ACRS) reported increase decrease in accounts receivable prepaid expense and other assets of -$742K in Q1 2026.
- What does increase decrease in accounts receivable prepaid expense and other assets mean?
- This metric tracks the net change in working capital tied to receivables, prepaid expenses, and other short-term assets. It indicates how effectively the company manages its cash conversion cycle and the timing of cash inflows relative to revenue recognition. A significant increase may signal potential liquidity constraints or changes in customer payment behavior.